How do you approach a stage IIIC triple positive IDC, s/p neoadjuvant TCH and P, lumpectomy, and ALND with significant residual disease at the time of surgery?
Would you recommend additional cytotoxic chemotherapy and/or switch her anti-Her therapy to T-DM1?
@Debu Tripathy, Could you please explain this conc...
I believe this uncertainty is related to the fact ...